 WALTHAM, Mass., Jan. 03, 2022 GLOBE NEWSWIRE -- Apellis Pharmaceuticals , Inc. Nasdaq: APLS, a global biopharmaceutical company and leader in complement, today announced that the company will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022 at 8:15 a.m. ET. 